Supplement
Lactobacillus reuteri is a probiotic bacterium that lives naturally in the gut, where it helps shape the microbe community. People mainly look at it for acute diarrhea from gastroenteritis, where the evidence is strong, and trials also found babies with colic cried less and H. pylori outcomes improved. The colic and H. pylori findings came from small or moderate studies and the evidence is moderate, while blood sugar and cholesterol showed no clear difference.
Sources: PMID 37962097; PMID 38846173
- Updated
- How we grade
- 30 studies cited
- Best evidence
- Grade B
- Conditions studied
- 21
- Outcomes
- 89
- Graded outcomes
- 0555
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
Infantile Colic
H. Pylori Infection
- Helicobacter Pylori Infection Signs: improves
- Gastrointestinal symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Helicobacter Pylori Infection Signs Small Improvement | Improves (the measure goes up) | Small effect | 3 studies | 1,087 people | ||
Studies that measured helicobacter pylori infection signs
| ||||||
| Gastrointestinal symptoms Small Improvement | Improves (the measure goes down) | Small effect | 396 people | |||
H. Pylori Infection
- Gastrointestinal symptoms: improves
- Helicobacter Pylori Infection Signs: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gastrointestinal symptoms Small Improvement | Improves (the measure goes down) | Small effect | 396 people | |||
| Helicobacter Pylori Infection Signs | Improves (the measure goes up) | 3 studies | 1,087 people | |||
Studies that measured helicobacter pylori infection signs
| ||||||
Digestive Health
- Constipation Signs and Symptoms: improves
- Infant crying: improves
- Immunity: improves
Constipation
- Constipation Signs and Symptoms: improves
- Fecal Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Constipation Signs and Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 44 people | |||
| Fecal Weight | Improves (the measure goes down) | 1 study | 44 people | |||
Studies that measured fecal weight | ||||||
Cystic Fibrosis
- Cystic Fibrosis Symptoms: improves
- Lung Function: improves
- TNF-Alpha: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cystic Fibrosis Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 120 people | |||
| Lung Function | Improves (the measure goes up) | 1 study | 60 people | |||
| TNF-Alpha | Improves (the measure goes down) | 1 study | 60 people | |||
Studies that measured tnf-alpha | ||||||
| Interleukin 8 | Changes; see studies | 60 people | ||||
| Upper Respiratory Tract Infection Risk | Changes; see studies | 60 people | ||||
High Cholesterol
- Apolipoprotein A
- Apolipoprotein B: improves
- Plasma Vitamin D: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A No effect | NoneNo effect | 127 people | ||||
| Apolipoprotein B | Improves (the measure goes down) | 2 studies | 241 people | |||
Studies that measured apolipoprotein b | ||||||
| Plasma Vitamin D | Improves (the measure goes up) | 1 study | 127 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 241 people | |||
Studies that measured triglycerides | ||||||
| Bilirubin | Changes; see studies | 114 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 127 people | ||||
| Fecal Bile Acids | Improves (the measure goes up) | 114 people | ||||
| Fibrinogen | Improves (the measure goes up) | 127 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 241 people | ||||
| Kidney Function | Improves (the measure goes up) | 114 people | ||||
| Liver Enzymes | Changes; see studies | 114 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 241 people | ||||
| Plasma Vitamin E | Improves (the measure goes up) | 127 people | ||||
| Plasma β-carotene | Improves (the measure goes up) | 127 people | ||||
| Total cholesterol | Improves (the measure goes down) | 241 people | ||||
Immune Health
- B Cell Count
- Immunity: improves
- Immunoglobulin A: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 31 people | ||||
| Immunity | Improves (the measure goes up) | 1 study | 31 people | |||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 23 people | |||
Studies that measured immunoglobulin a | ||||||
| Lymphocyte Count | Improves (the measure goes up) | 31 people | ||||
| Monocyte Count | Improves (the measure goes up) | 31 people | ||||
General Cardiovascular Health
- Blood glucose
- Blood Pressure: improves
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 385 people | ||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 385 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 268 people | |||
Studies that measured triglycerides | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 268 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 268 people | ||||
| Total cholesterol | Improves (the measure goes down) | 268 people | ||||
Human Immunodeficiency Virus (HIV)
- Bilirubin
- Blood Pressure: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bilirubin No effect | NoneNo effect | 39 people | ||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 39 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 39 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 39 people | |||
Studies that measured triglycerides | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 39 people | ||||
| Kidney Function | Improves (the measure goes up) | 39 people | ||||
| Liver Enzymes | Changes; see studies | 39 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 39 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 39 people | ||||
| Monocyte Count | Improves (the measure goes up) | 39 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 39 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 39 people | ||||
| Serum Platelets | Improves (the measure goes up) | 39 people | ||||
| Total cholesterol | Improves (the measure goes down) | 39 people | ||||
| Weight | Improves (the measure goes down) | 39 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 39 people | ||||
Metabolic Health
- Bilirubin
- Blood Pressure: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bilirubin No effect | NoneNo effect | 124 people | ||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 124 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 124 people | |||
| Blood glucose | Improves (the measure goes down) | 124 people | ||||
| Hematocrit | Improves (the measure goes up) | 124 people | ||||
| Hemoglobin | Improves (the measure goes up) | 124 people | ||||
| Liver Enzymes | Changes; see studies | 124 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 124 people | ||||
| Weight | Improves (the measure goes down) | 124 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 124 people | ||||
Acute Gastroenteritis
- Diarrhea Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Diarrhea Symptoms | Improves (the measure goes down) | 4 studies | 433 people |
Antibiotic-Associated Diarrhea (AAD)
- Diarrhea Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Diarrhea Symptoms | Improves (the measure goes down) | 4 studies | 23 people |
Diarrhea
- Diarrhea Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Diarrhea Symptoms | Improves (the measure goes down) | 4 studies | 540 people |
Allergic Rhinitis (Seasonal Allergies / Hay Fever)
- Allergic Disease Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergic Disease Risk | Changes; see studies | 1 study | 184 people |
Asthma
- Allergic Disease Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergic Disease Risk | Changes; see studies | 1 study | 184 people |
Depression
- Depression Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms | Improves (the measure goes down) | 1 study | 509 people |
General Gut Health
- Immunoglobulin A: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 23 people |
Functional Gastrointestinal Disorders
- Abdominal Pain: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Abdominal Pain | Improves (the measure goes down) | 1 study | 481 people |
Peri-implant diseases
- Dental Health Metrics: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Dental Health Metrics | Improves (the measure goes up) | 1 study | 196 people |
Key findings
- Infant cryingImproves (the measure goes up)
- Helicobacter Pylori Infection SignsImproves (the measure goes up)
- Gastrointestinal symptomsImproves (the measure goes down)
Shop the evidence-backed picks
Third-party tested Lactobacillus reuteri products, in the forms the graded studies used where we can match them.
- Grade B
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
30 studies from PubMed
- Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial
- Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults
- Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
- Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial
- Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus
- Probiotics for infantile colic: Is there evidence beyond doubt? A meta-analysis and systematic review.
- Probiotics to prevent or treat excessive infant crying: systematic review and meta-analysis
- Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial
- Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial
- Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial
- Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study
- 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938
- Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial
- Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study
- Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial
- Salivary IgA response to probiotic bacteria and mutans streptococci after the use of chewing gum containing Lactobacillus reuteri
- Lactobacillus reuteri ATCC55730 in cystic fibrosis
- A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults
- No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy
- Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study
- Lactobacillus reuteri compared with placebo as an adjuvant in Helicobacter pylori eradication therapy: a meta-analysis of randomized controlled trials.
- Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study
- Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans
- The efficacy and acceptability of Lactobacillus reuteri for the treatment of depression: A systematic review and meta-analysis.
- Probiotics for treating acute infectious diarrhoea.
- The influence of probiotics on gastrointestinal tract infections among children attending childcare: A systematic review and meta-analysis
- A systematic review and meta-analysis: the therapeutic and preventive effect of Lactobacillus reuteri DSM 17,938 addition in children with diarrhea.
- Use of probiotics in the treatment of functional abdominal pain in children-systematic review and meta-analysis
- Limosilactobacillus reuteri consumption significantly reduces the total cholesterol concentration without affecting other cardiovascular disease risk factors in adults: A systematic review and meta-analysis.
- Adjunctive benefit of probiotic supplementation along with nonsurgical therapy for peri-implant diseases - A systematic review and meta-analysis.